Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Sinusitis
Do you use AIT as an adjunct therapy in addition to nasal sprays and oral medications for CRS?
Related Questions
What treatment approach do you suggests for a patient with nasal polyp disease and asthma who was improved on dupilumab, but over last 2 years has begun to have increased nasal symptoms and rising eosinophil counts?
Do you consider immunoglobulin replacement in a patient who has rapidly waning vaccine titers but does appropriately respond to revaccination?
When would you favor initiation of mepolizumab versus dupilumab for CRSwNP?
When do you consider extending the dosing interval for patients on biologics with CRSwNP?
What are the implications of checking post-vaccine titers after administration of Prevnar 20 compared to PPSV23?
How do you approach performing a food challenge in a patient with CSU who is dependent on their H1 blockers?
What medications would you have a patient avoid with an IgE mediated reaction to cyclobenzaprine?
How do you approach patients who develop eczema flare after food exposure?
How do you approach hypogammaglobulinemia in a patient with sarcoidosis?
For a positive anti-TPO and normal TSH in the workup of CSU, are you referring to endocrinology?
